Calls
1
u/Analyst-man
Reddit r/ValueInvesting
Win Rate
100.0%
return
+5.4%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Apr 16
$95.57
+5.4%
ABT trades at 18x forward P/E, is growing mid-single digits, pays a >2.5% dividend, and recently made a $21B acquisition in colorectal testing. The author sees this combination of valuation, growth, yield, and strategic expansion as creating a value investment opportunity. The post implies a long-term buy-and-hold investment in a diversified healthcare leader. Acquisition integration risk, slower-than-expected growth, multiple compression if earnings disappoint, or broader healthcare sector headwinds.
ABT trades at 18x forward P/E, is growing mid-single digits, pays a >2.5% dividend, and recently made a $21B acquisition in colorectal testing. The author sees this combination of valuation, growth, yield, and strategic expansion as creating a value investment opportunity. The post implies a long-term buy-and-hold investment in a diversified healthcare leader. Acquisition integration risk, slower-than-expected growth, multiple compression if earnings disappoint, or broader healthcare sector headwinds.
MedTech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Analyst-man has 1 trade ideas tracked on Buzzberg across 1 tickers since April 2026. Most covered: ABT.
